Esba, 2020 NCT04334629
anti-inflammatory therapies vs. standard of care
COVID-19 (hospitalized or not)
Wei, 2022
casirivimab/imdevimab (Ronapreve) vs. standard of care
COVID-19 (hospitalized or not)
Manenti, 2021
colchicine vs. standard of care
COVID-19 (hospitalized or not)
Wu, 2020
corticosteroids vs. control
COVID-19 (hospitalized or not)
Husain, 2020
corticosteroids vs. placebo
COVID-19 (hospitalized or not)
Kragholm, 2020
Ibuprofen vs. control
COVID-19 (hospitalized or not)
Rinott, 2020
Ibuprofen vs. control
COVID-19 (hospitalized or not)
Arico, 2021 2020-003872-42
IFN beta-1a vs. standard of care
COVID-19 (hospitalized or not)
Roostaei, 2021
levamisole vs. placebo
COVID-19 (hospitalized or not)
Gianfransesco, 2020
non-steroidal anti-inflammatory drugs vs. control
COVID-19 (hospitalized or not)
Lund, 2020
non-steroidal anti-inflammatory drugs vs. control
COVID-19 (hospitalized or not)
Kragholm, 2021
non-steroidal anti-inflammatory drugs vs. control
COVID-19 (hospitalized or not)
Abu Esba LC (any NSAID use, acute and chronic), 2020
non-steroidal anti-inflammatory drugs vs. control
COVID-19 (hospitalized or not)
Park, 2021
non-steroidal anti-inflammatory drugs vs. paracetamol
COVID-19 (hospitalized or not)
Zhang, 2020
statins vs. control
COVID-19 (hospitalized or not)
Rimland, 2020
tocilizumab vs. control
COVID-19 (hospitalized or not)
Hong Zhao, 2021 NCT04310228
tocilizumab vs. favipiravir
COVID-19 (hospitalized or not)
IMMUNONCOVID (tocilizumab)), 0 NCT04333914
tocilizumab vs. standard of care
COVID-19 (hospitalized or not)
